EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Myeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report

Meha Krishnareddigari, Gopal Patel, Aqiba Bokhari iD, John Paul Graff, Denis M Dwyre iD, Arun Panigrahi

Hematology Reports · 06.08.2026 · 18 (4) · 56

DOI: 10.3390/hematolrep18040056 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hematology Reports, online erschienen am 06.08.2026. Verfasst von Meha Krishnareddigari und 5 weiteren Autor:innen. Beteiligte Einrichtung: UCLA Health, University of California, Los Angeles, CA 90025, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myeloid/lymphoid neoplasms with FGFR1 rearrangement (MLN-FGFR1), also known as 8p11 myeloproliferative syndrome, are rare and aggressive hematologic malignancies arising from pluripotent stem cells. The FGFR1::ZMYM2 fusion resulting from t(8;13)(p11.2;q12) characteristically co presents as T-lymphoblastic lymphoma in lymph nodes alongside a myeloproliferative neoplasm in the bone marrow. The disease is resistant to tyrosine kinase inhibitors and conventional chemotherapy, and carries a median survival of less than 12 months without allogeneic hematopoietic stem cell transplantation (allo-HSCT). Case Presentation: We report a 23-year-old female who presented with progressive cervical lymphadenopathy and hyperleukocytosis (WBC 186.6 K/μL). Excisional lymph node biopsy demonstrated T-cell acute lymphoblastic lymphoma (T-ALL) with eosinophilic infiltration; immunohistochemistry confirmed lymphoblasts positive for CD1a, CD2, CD3, CD4, CD5, CD7, CD8, and TdT. Concurrent bone marrow biopsy showed a myeloproliferative neoplasm without excess blasts. Chromosomal analysis confirmed t(8;13)(p11.2;q12) with FGFR1::ZMYM2 rearrangement, and NGS identified a concurrent CSF3R variant (Q741*). She received induction chemotherapy per the PEDS AALL1231 protocol (Arm A) followed by consolidation, with a course complicated by hyperleukocytosis, venous thromboembolism, E. coli bacteremia, and severe mucositis requiring PICU admission. Despite initial response, the disease progressed to acute myeloid leukemia (AML) with acquisition of a PTEN variant; the patient was offered but did not complete allo-HSCT and died of refractory AML approximately 10 months after diagnosis.

Conclusions

This case highlights the aggressive clinical course and diagnostic challenges of MLN-FGFR1, a rare stem cell-derived myeloid/lymphoid neoplasm. To our knowledge, this appears to be the first reported case documenting sequential CSF3R and PTEN variant acquisition with complete follow-up through fatal AML transformation, and the first to describe treatment with a pediatric ALL induction protocol (PEDS AALL1231) in this setting. The characteristic histomorphologic pattern of eosinophil-rich T-ALL in lymph nodes with concurrent myeloproliferative neoplasm in bone marrow should prompt immediate molecular workup. Allo-HSCT must be pursued urgently at diagnosis, as complications rapidly narrow the transplant window and the disease is uniformly fatal without it.

Schlagwörter

Stichwörter der Autor:innen

8p11 myeloproliferative syndromeCSF3RFGFR1 rearrangementPTENT-cell acute lymphoblastic lymphomaZMYM2acute myeloid leukemiahematopoietic stem cell transplantationmyeloproliferative neoplasm

Autor:innen und Institutionen

  • UCLA Health, University of California, Los Angeles, CA 90025, USA.
  • Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA 90095, USA.

ORCID-Profile: Aqiba Bokhari, Denis M Dwyre

Zitieren

APA

Krishnareddigari, M., Patel, G., Bokhari, A., Graff, J. P., Dwyre, D. M., & Panigrahi, A. (2026). Myeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report. Hematology Reports, 18(4), 56. https://doi.org/10.3390/hematolrep18040056

Vancouver

Krishnareddigari M, Patel G, Bokhari A, Graff JP, Dwyre DM, Panigrahi A. Myeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report. Hematology Reports. 2026;18(4):56. doi:10.3390/hematolrep18040056

BibTeX
@article{Krishnareddigari2026,
  author = {Krishnareddigari, Meha and Patel, Gopal and Bokhari, Aqiba and Graff, John Paul and Dwyre, Denis M and Panigrahi, Arun},
  title = {Myeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report},
  journal = {Hematology Reports},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {56},
  doi = {10.3390/hematolrep18040056}
}
Kostenlos starten →